News

Agrospheres Seeks EPA Approval For Inert Ingredient

AgroSpheres, Inc. progresses toward a key milestone in reducing pesticide impact in the environment. The submission of AgroSpheres™ Inert ingredient to the US Environmental Protection Agency (EPA) for use in agriculture inputs will further the company’s objective to make biopesticides more effective and reduce the rates of synthetic pesticide application. When approved, this technology will power a suite of environmentally-friendly crop health products for organic and conventional farming.

“The EPA submission marks our first major milestone towards the commercial establishment of our biorational portfolio which will bring sustainable products to our farmers and sustainable returns to our shareholders,” said Payam Pourtaheri, AgroSpheres’ CoFounder and CEO.

AgroSpheres™ Inert is a non-GM, fermentation-derived technology that will enhance biorational products. By replacing conventional inert ingredients like solvents and microplastics, this new technology will create an effective, biobased and biodegradable product line for growers.

“With this initial EPA submission, we are on track to deliver the first organic, inert technology that can transform the performance of both biological and synthetic pesticides,” said AgroSpheres’ CoFounder and CTO Ameer Shakeel. “Growers and investors can be confident we’re producing this ingredient in a controlled, zero-waste and proprietary bioprocess.”

“The AgroSpheres inert technology is both simple and elegant”, said Jerry Hjelle, Ph.D., AgroSpheres Scientific Advisor. “It is produced from a well-understood microbe with an established safety history. It enables a sustained release of organic, biological and conventional pesticides, creating the opportunity to reduce global pesticide use. The non-viable inert ingredient degrades in soil just like any other soil microorganism. This innovative approach to protecting organic and conventional foods and feeds has great potential.”

AgroSpheres developed the Inert technology to power eco-friendly ag product performance and significantly reduce chemical usage. The company is engaging leading global commercial partners that will enable broad access to reliable and novel biorational products. AgroSpheres™ Inert technology will empower crop health products that move us closer to realizing the company’s vision of a future built by nature’s technologies.

Recent News

06/11/2026

Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing

Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that it has acquired Azora Therapeutics, Inc. (“Azora”), a biopharmaceutical company developing treatments for serious inflammatory diseases. The acquisition brings Azora’s lead asset AT177, a proprietary colon‑targeted aryl hydrocarbon receptor (AhR) agonist designed to enable localized activation with limited systemic exposure, into Adial’s pipeline.

06/11/2026

Luna Labs Launches 3 Waves Venture Spinout to Commercialize Advanced Vestibular Stimulation Technology

Luna Labs today announced the launch of 3 Waves, Inc. (“3Waves”), a dual-use spinout company that was established to commercialize advanced virtual and mixed reality technologies for defense, commercial simulation, and medical applications. As part of the spinout, 3Waves and Mayo Clinic executed an exclusive license to support the development of next-generation vestibular stimulation systems

06/02/2026

TearSolutions Receives FDA Orphan Drug and Fast Track Designations for Lacripep® in Neurotrophic Keratitis and Initiates Phase 2 Clinical Trial with First Patients Dosed

TearSolutions, Inc. (“TearSolutions”), a clinical-stage biotechnology company developing novel ophthalmic therapeutics, today announced receiving Food and Drug Administration (FDA) Orphan Drug (ODD) and Fast Track Designations for Lacripep in Neurotrophic Keratitis (NK) and initiating a Phase 2 clinical trial with first patients dosed. The FDA’s ODD provides incentives, including tax credits for clinical testing and